Effect of the ATP-binding cassette drug transporters ABCB1, ABCG2, and ABCC2 on erlotinib hydrochloride (Tarceva) disposition in in vitro and in vivo pharmacokinetic studies employing Bcrp1-/-/Mdr1a/1b-/- (triple-knockout) and wild-type mice

Molecular Cancer Therapeutics
Serena MarchettiJan H M Schellens

Abstract

We tested whether erlotinib hydrochloride (Tarceva, OSI-774), an orally active epidermal growth factor receptor tyrosine kinase inhibitor, is a substrate for the ATP-binding cassette drug transporters P-glycoprotein (P-gp; MDR1, ABCB1), breast cancer resistance protein (BCRP; ABCG2), and multidrug resistance protein 2 (MRP2; ABCC2) in vitro and whether P-gp and BCRP affect the oral pharmacokinetics of erlotinib hydrochloride in vivo. In vitro cell survival, drug transport, accumulation, and efflux of erlotinib were done using Madin-Darby canine kidney II [MDCKII; wild-type (WT), MDR1, Bcrp1, and MRP2] and LLCPK (WT and MDR1) cells and monolayers as well as the IGROV1 and the derived human BCRP-overexpressing T8 cell lines. In vivo, the pharmacokinetics of erlotinib after p.o. and i.p. administration was studied in Bcrp1/Mdr1a/1b(-/-) (triple-knockout) and WT mice. In vitro, erlotinib was actively transported by P-gp and BCRP/Bcrp1. No active transport of erlotinib by MRP2 was observed. In vivo, systemic exposure (P = 0.01) as well as bioavailability of erlotinib after oral administration (5 mg/kg) were statistically significantly increased in Bcrp1/Mdr1a/1b(-/-) knockout mice (60.4%) compared with WT mice (40.0%; P = 0.02). Erl...Continue Reading

References

Feb 1, 1994·The Journal of Urology·M J SiegsmundM M Gottesman
Jul 20, 1999·The Journal of Clinical Investigation·B GreinerH K Kroemer
Feb 22, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M M MalingréJ H Schellens
Apr 12, 2001·The Journal of Biological Chemistry·A GeickO Burk
Sep 18, 2001·Biological & Pharmaceutical Bulletin·N IidaK Okumura
Jun 5, 2002·Annual Review of Biochemistry·P Borst, R Oude Elferink
Jun 29, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C M F KruijtzerJ H M Schellens
Jan 22, 2003·Advanced Drug Delivery Reviews·Alfred H Schinkel, Johan W Jonker
Oct 25, 2003·Oncogene·Gary D Kruh, Martin G Belinsky
May 25, 2004·Molecular Pharmacology·Csilla Ozvegy-LaczkaBalázs Sarkadi
Oct 20, 2004·Cancer Research·Clinton F StewartPeter J Houghton
Jun 9, 2005·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Csilla Ozvegy-LaczkaBalázs Sarkadi
Jun 16, 2005·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Takeshi KitazakiShigeru Kohno
Sep 17, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·John R JohnsonRichard Pazdur
Dec 31, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jie LingChandra Prakash
May 3, 2006·Cancer Research·Markos LeggasClinton F Stewart
Dec 6, 2006·Cancer Research·Yanli ZhuangClinton F Stewart
Jun 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jing LiSharyn D Baker
Nov 3, 2007·The Journal of Clinical Investigation·Antonius E van HerwaardenAlfred H Schinkel

❮ Previous
Next ❯

Citations

Jun 30, 2009·Journal of Neuro-oncology·David A ReardonHenry S Friedman
Mar 1, 2013·European Journal of Drug Metabolism and Pharmacokinetics·C JoveletS Gil
Feb 20, 2013·Clinical Pharmacokinetics·Frederik E StuurmanJan H M Schellens
Sep 28, 2012·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Sagar AgarwalWilliam F Elmquist
Jan 28, 2010·Pharmacological Reviews·Curtis D Klaassen, Lauren M Aleksunes
Jun 24, 2009·Journal of Oncology·Jana RolffIduna Fichtner
Sep 24, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shuiying HuSharyn D Baker
Nov 20, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mohamed A ElmeliegyClinton F Stewart
Mar 5, 2011·Biological & Pharmaceutical Bulletin·Yoshihiko ShibayamaKatsushi Yamada
Sep 3, 2013·Biological & Pharmaceutical Bulletin·Takuro KoboriShogo Tokuyama
Apr 7, 2011·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Ayaka NawaShogo Tokuyama
Feb 2, 2012·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Ayaka NawaShogo Tokuyama
May 11, 2011·Clinical Pharmacokinetics·Matthias SchefflerUwe Fuhr
Jan 13, 2012·Chinese Journal of Cancer·Miao He, Min-Jie Wei
Oct 22, 2010·Investigational New Drugs·Nienke A de VriesOlaf van Tellingen
Apr 2, 2013·The AAPS Journal·Thomayant PrueksaritanontJerome Hochman
Sep 6, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Nagaraju AnreddyZhe-Sheng Chen
Aug 6, 2010·Expert Opinion on Drug Metabolism & Toxicology·Derek R Duckett, Michael D Cameron
Apr 7, 2010·Expert Opinion on Drug Metabolism & Toxicology·Carole GiraudJean-Marc Treluyer
Jan 8, 2013·Expert Opinion on Drug Metabolism & Toxicology·Rebecca Schnepf, Oliver Zolk
Oct 14, 2014·Journal of Pharmaceutical Sciences·Jie ShaoGuohua An
Jan 22, 2013·Journal of Pharmaceutical Sciences·Ramola SaneWilliam F Elmquist
Jun 25, 2015·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Christina S BaikLaura Q Chow
Jan 8, 2016·European Journal of Medicinal Chemistry·Hang ZhongLinxiang Zhao
May 8, 2015·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Takuro KoboriShogo Tokuyama
Jan 18, 2012·Biochemical Pharmacology·Karthika NatarajanDouglas D Ross
Nov 30, 2010·Journal of Pharmacological and Toxicological Methods·Robert W RobeySusan E Bates
Dec 31, 2015·Journal of Experimental & Clinical Cancer Research : CR·David Westover, Fengzhi Li
Jan 20, 2010·Current Problems in Cancer·Helen X ChenJanet E Dancey
Sep 8, 2009·Cancer Treatment Reviews·Nielka P van ErpHenk-Jan Guchelaar
Jan 13, 2009·Advanced Drug Delivery Reviews·Robert W RobeySusan E Bates
Jun 8, 2011·Journal of Veterinary Pharmacology and Therapeutics·K L Mealey
Mar 17, 2012·The Journal of Pharmacy and Pharmacology·Wakako Fujita-HamabeShogo Tokuyama
Aug 11, 2011·British Journal of Pharmacology·K ManderyM F Fromm
Dec 24, 2010·British Journal of Clinical Pharmacology·Rob Ter HeineMirte M Malingré
Feb 26, 2013·International Journal of Cancer. Journal International Du Cancer·Fan LinOlaf van Tellingen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.